| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | VANGUARD INDEX FDS | 2,155,100 | 230,941,000 | 24.24% | ||
| 2 | OPHTHOTECH CORP COM | 3,610,487 | 184,243,000 | 19.34% | ||
| 3 | INOGEN INC COM | 3,549,320 | 177,856,000 | 18.67% | ||
| 4 | VANGUARD INTL EQUITY INDEX F | 2,101,000 | 98,033,000 | 10.29% | ||
| 5 | REATA PHARMACEUTICALS INC | 3,367,763 | 66,513,000 | 6.98% | ||
| 6 | CORVUS PHARMACEUTICALS INC COM | 3,224,046 | 45,975,000 | 4.83% | ||
| 7 | TOBIRA THERAPEUTICS INC | 2,027,091 | 25,460,000 | 2.67% | ||
| 8 | COLUCID PHARMACEUTICALS INC COM | 3,056,563 | 24,972,000 | 2.62% | ||
| 9 | ACCELERON PHARMA | 685,863 | 23,306,000 | 2.45% | ||
| 10 | SPECTRANETICS CORP | 1,117,002 | 20,899,000 | 2.19% | ||
| 11 | FLEXION THERAPEUTICS INC COM | 950,161 | 14,224,000 | 1.49% | ||
| 12 | MERUS N V | 1,410,417 | 11,269,000 | 1.18% | ||
| 13 | INVUITY INC | 1,075,448 | 10,249,000 | 1.08% | ||
| 14 | Nabriva Therapeutics AG | 1,054,823 | 7,911,000 | 0.83% | ||
| 15 | WRIGHT MED GROUP N V | 4,622,032 | 5,824,000 | 0.61% | PRN | |
| 16 | HTG MOLECULAR DIAGNOSTICS IN | 1,280,185 | 3,482,000 | 0.37% | ||
| 17 | XENON PHARMACEUTICALS INC | 127,563 | 753,000 | 0.08% | ||
| 18 | TOKAI PHARMACEUTICALS INC | 128,993 | 711,000 | 0.07% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-019962, filed 2016.08.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
